nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosuvastatin—SLCO1A2—Chlorambucil—testicular cancer	0.127	0.143	CbGbCtD
Rosuvastatin—ABCC1—Dactinomycin—testicular cancer	0.0684	0.0769	CbGbCtD
Rosuvastatin—ABCB11—Vinblastine—testicular cancer	0.0603	0.0678	CbGbCtD
Rosuvastatin—ABCC1—Epirubicin—testicular cancer	0.0495	0.0557	CbGbCtD
Rosuvastatin—ABCG2—Dactinomycin—testicular cancer	0.0458	0.0515	CbGbCtD
Rosuvastatin—ABCC1—Vinblastine—testicular cancer	0.0429	0.0482	CbGbCtD
Rosuvastatin—ABCC1—Etoposide—testicular cancer	0.0386	0.0434	CbGbCtD
Rosuvastatin—ABCB11—Doxorubicin—testicular cancer	0.0371	0.0417	CbGbCtD
Rosuvastatin—SLCO1B3—Methotrexate—testicular cancer	0.0369	0.0415	CbGbCtD
Rosuvastatin—ABCC4—Methotrexate—testicular cancer	0.0317	0.0357	CbGbCtD
Rosuvastatin—ABCG2—Carboplatin—testicular cancer	0.0308	0.0346	CbGbCtD
Rosuvastatin—CYP3A5—Ifosfamide—testicular cancer	0.0299	0.0337	CbGbCtD
Rosuvastatin—ABCC1—Doxorubicin—testicular cancer	0.0263	0.0296	CbGbCtD
Rosuvastatin—ABCG2—Cisplatin—testicular cancer	0.0263	0.0296	CbGbCtD
Rosuvastatin—ABCG2—Etoposide—testicular cancer	0.0258	0.029	CbGbCtD
Rosuvastatin—ABCC1—Methotrexate—testicular cancer	0.0255	0.0287	CbGbCtD
Rosuvastatin—CYP2C19—Ifosfamide—testicular cancer	0.0242	0.0272	CbGbCtD
Rosuvastatin—SLCO1A2—Methotrexate—testicular cancer	0.0228	0.0256	CbGbCtD
Rosuvastatin—SLCO1B1—Methotrexate—testicular cancer	0.0215	0.0242	CbGbCtD
Rosuvastatin—CYP2C9—Ifosfamide—testicular cancer	0.0201	0.0226	CbGbCtD
Rosuvastatin—ABCG2—Doxorubicin—testicular cancer	0.0176	0.0198	CbGbCtD
Rosuvastatin—ABCG2—Methotrexate—testicular cancer	0.0171	0.0192	CbGbCtD
Rosuvastatin—CYP3A5—Etoposide—testicular cancer	0.0143	0.0161	CbGbCtD
Rosuvastatin—ALB—Methotrexate—testicular cancer	0.0118	0.0132	CbGbCtD
Rosuvastatin—CYP3A4—Ifosfamide—testicular cancer	0.0117	0.0131	CbGbCtD
Rosuvastatin—CYP2C9—Cisplatin—testicular cancer	0.00977	0.011	CbGbCtD
Rosuvastatin—CYP3A4—Vinblastine—testicular cancer	0.0062	0.00697	CbGbCtD
Rosuvastatin—CYP3A4—Etoposide—testicular cancer	0.00558	0.00627	CbGbCtD
Rosuvastatin—CYP3A4—Doxorubicin—testicular cancer	0.00381	0.00428	CbGbCtD
Rosuvastatin—Neuropathy peripheral—Cisplatin—testicular cancer	0.000442	0.00419	CcSEcCtD
Rosuvastatin—Pain—Chlorambucil—testicular cancer	0.000431	0.00409	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Cisplatin—testicular cancer	0.000427	0.00404	CcSEcCtD
Rosuvastatin—Arrhythmia—Ifosfamide—testicular cancer	0.00042	0.00398	CcSEcCtD
Rosuvastatin—Cough increased—Doxorubicin—testicular cancer	0.000419	0.00397	CcSEcCtD
Rosuvastatin—Cough—Bleomycin—testicular cancer	0.000418	0.00396	CcSEcCtD
Rosuvastatin—Feeling abnormal—Chlorambucil—testicular cancer	0.000416	0.00394	CcSEcCtD
Rosuvastatin—Paraesthesia—Vinblastine—testicular cancer	0.000415	0.00394	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000413	0.00391	CcSEcCtD
Rosuvastatin—Mental disorder—Ifosfamide—testicular cancer	0.000412	0.0039	CcSEcCtD
Rosuvastatin—HMGCR—seminal vesicle—testicular cancer	0.00041	0.0806	CbGeAlD
Rosuvastatin—Myalgia—Bleomycin—testicular cancer	0.000407	0.00386	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Etoposide—testicular cancer	0.000405	0.00384	CcSEcCtD
Rosuvastatin—Jaundice—Etoposide—testicular cancer	0.000403	0.00382	CcSEcCtD
Rosuvastatin—Urticaria—Chlorambucil—testicular cancer	0.000401	0.0038	CcSEcCtD
Rosuvastatin—Abdominal pain—Chlorambucil—testicular cancer	0.000399	0.00378	CcSEcCtD
Rosuvastatin—Gynaecomastia—Methotrexate—testicular cancer	0.000396	0.00375	CcSEcCtD
Rosuvastatin—Pain—Vinblastine—testicular cancer	0.000395	0.00375	CcSEcCtD
Rosuvastatin—Constipation—Vinblastine—testicular cancer	0.000395	0.00375	CcSEcCtD
Rosuvastatin—Confusional state—Bleomycin—testicular cancer	0.000394	0.00373	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Etoposide—testicular cancer	0.000391	0.00371	CcSEcCtD
Rosuvastatin—Infection—Bleomycin—testicular cancer	0.000388	0.00368	CcSEcCtD
Rosuvastatin—SLC7A11—female gonad—testicular cancer	0.000387	0.0761	CbGeAlD
Rosuvastatin—Thrombocytopenia—Bleomycin—testicular cancer	0.000382	0.00362	CcSEcCtD
Rosuvastatin—Feeling abnormal—Vinblastine—testicular cancer	0.000381	0.00361	CcSEcCtD
Rosuvastatin—Myalgia—Dactinomycin—testicular cancer	0.00038	0.0036	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Vinblastine—testicular cancer	0.000378	0.00358	CcSEcCtD
Rosuvastatin—Angioedema—Ifosfamide—testicular cancer	0.000374	0.00354	CcSEcCtD
Rosuvastatin—Hypersensitivity—Chlorambucil—testicular cancer	0.000372	0.00352	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Methotrexate—testicular cancer	0.000369	0.0035	CcSEcCtD
Rosuvastatin—Abdominal pain—Vinblastine—testicular cancer	0.000366	0.00347	CcSEcCtD
Rosuvastatin—Hypertonia—Epirubicin—testicular cancer	0.000363	0.00344	CcSEcCtD
Rosuvastatin—Asthenia—Chlorambucil—testicular cancer	0.000362	0.00343	CcSEcCtD
Rosuvastatin—Infection—Dactinomycin—testicular cancer	0.000362	0.00343	CcSEcCtD
Rosuvastatin—Arrhythmia—Cisplatin—testicular cancer	0.000362	0.00343	CcSEcCtD
Rosuvastatin—Hepatic failure—Methotrexate—testicular cancer	0.000357	0.00339	CcSEcCtD
Rosuvastatin—Pruritus—Chlorambucil—testicular cancer	0.000357	0.00338	CcSEcCtD
Rosuvastatin—Cough—Ifosfamide—testicular cancer	0.000357	0.00338	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Dactinomycin—testicular cancer	0.000357	0.00338	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000356	0.00337	CcSEcCtD
Rosuvastatin—Paraesthesia—Bleomycin—testicular cancer	0.000351	0.00332	CcSEcCtD
Rosuvastatin—Arthralgia—Ifosfamide—testicular cancer	0.000348	0.0033	CcSEcCtD
Rosuvastatin—Myalgia—Ifosfamide—testicular cancer	0.000348	0.0033	CcSEcCtD
Rosuvastatin—Renal failure acute—Methotrexate—testicular cancer	0.000348	0.0033	CcSEcCtD
Rosuvastatin—Flatulence—Cisplatin—testicular cancer	0.000347	0.00329	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Epirubicin—testicular cancer	0.000346	0.00328	CcSEcCtD
Rosuvastatin—Diarrhoea—Chlorambucil—testicular cancer	0.000345	0.00327	CcSEcCtD
Rosuvastatin—SLC7A11—testis—testicular cancer	0.000343	0.0675	CbGeAlD
Rosuvastatin—Hypersensitivity—Vinblastine—testicular cancer	0.000341	0.00323	CcSEcCtD
Rosuvastatin—Confusional state—Ifosfamide—testicular cancer	0.000337	0.00319	CcSEcCtD
Rosuvastatin—Hypertonia—Doxorubicin—testicular cancer	0.000336	0.00318	CcSEcCtD
Rosuvastatin—Hepatic failure—Epirubicin—testicular cancer	0.000335	0.00317	CcSEcCtD
Rosuvastatin—Pain—Bleomycin—testicular cancer	0.000334	0.00317	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000332	0.00315	CcSEcCtD
Rosuvastatin—Asthenia—Vinblastine—testicular cancer	0.000332	0.00314	CcSEcCtD
Rosuvastatin—Infection—Ifosfamide—testicular cancer	0.000332	0.00314	CcSEcCtD
Rosuvastatin—Nervous system disorder—Ifosfamide—testicular cancer	0.000327	0.0031	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Ifosfamide—testicular cancer	0.000327	0.0031	CcSEcCtD
Rosuvastatin—Renal failure acute—Epirubicin—testicular cancer	0.000326	0.00309	CcSEcCtD
Rosuvastatin—Feeling abnormal—Bleomycin—testicular cancer	0.000322	0.00305	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Doxorubicin—testicular cancer	0.00032	0.00303	CcSEcCtD
Rosuvastatin—Diarrhoea—Vinblastine—testicular cancer	0.000316	0.003	CcSEcCtD
Rosuvastatin—Pain—Dactinomycin—testicular cancer	0.000311	0.00295	CcSEcCtD
Rosuvastatin—Urticaria—Bleomycin—testicular cancer	0.00031	0.00294	CcSEcCtD
Rosuvastatin—Hepatic failure—Doxorubicin—testicular cancer	0.00031	0.00293	CcSEcCtD
Rosuvastatin—Dizziness—Vinblastine—testicular cancer	0.000306	0.0029	CcSEcCtD
Rosuvastatin—ABCB11—testis—testicular cancer	0.000305	0.06	CbGeAlD
Rosuvastatin—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000304	0.00288	CcSEcCtD
Rosuvastatin—Renal failure acute—Doxorubicin—testicular cancer	0.000301	0.00286	CcSEcCtD
Rosuvastatin—Myalgia—Cisplatin—testicular cancer	0.0003	0.00285	CcSEcCtD
Rosuvastatin—Feeling abnormal—Dactinomycin—testicular cancer	0.0003	0.00285	CcSEcCtD
Rosuvastatin—Nausea—Chlorambucil—testicular cancer	0.0003	0.00284	CcSEcCtD
Rosuvastatin—Paraesthesia—Ifosfamide—testicular cancer	0.0003	0.00284	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000298	0.00282	CcSEcCtD
Rosuvastatin—HMGCR—gonad—testicular cancer	0.000296	0.0582	CbGeAlD
Rosuvastatin—Breast disorder—Methotrexate—testicular cancer	0.00029	0.00275	CcSEcCtD
Rosuvastatin—Headache—Vinblastine—testicular cancer	0.00029	0.00275	CcSEcCtD
Rosuvastatin—Abdominal pain—Dactinomycin—testicular cancer	0.000288	0.00273	CcSEcCtD
Rosuvastatin—Hypersensitivity—Bleomycin—testicular cancer	0.000288	0.00273	CcSEcCtD
Rosuvastatin—Infection—Cisplatin—testicular cancer	0.000286	0.00271	CcSEcCtD
Rosuvastatin—Pain—Ifosfamide—testicular cancer	0.000285	0.00271	CcSEcCtD
Rosuvastatin—Constipation—Ifosfamide—testicular cancer	0.000285	0.00271	CcSEcCtD
Rosuvastatin—Nervous system disorder—Cisplatin—testicular cancer	0.000282	0.00268	CcSEcCtD
Rosuvastatin—Cough—Etoposide—testicular cancer	0.000282	0.00267	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Cisplatin—testicular cancer	0.000282	0.00267	CcSEcCtD
Rosuvastatin—Asthenia—Bleomycin—testicular cancer	0.00028	0.00266	CcSEcCtD
Rosuvastatin—Pruritus—Bleomycin—testicular cancer	0.000276	0.00262	CcSEcCtD
Rosuvastatin—Feeling abnormal—Ifosfamide—testicular cancer	0.000275	0.00261	CcSEcCtD
Rosuvastatin—Nausea—Vinblastine—testicular cancer	0.000275	0.0026	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000273	0.00259	CcSEcCtD
Rosuvastatin—Pancreatitis—Methotrexate—testicular cancer	0.000272	0.00258	CcSEcCtD
Rosuvastatin—Breast disorder—Epirubicin—testicular cancer	0.000272	0.00258	CcSEcCtD
Rosuvastatin—Hypersensitivity—Dactinomycin—testicular cancer	0.000268	0.00254	CcSEcCtD
Rosuvastatin—Confusional state—Etoposide—testicular cancer	0.000266	0.00252	CcSEcCtD
Rosuvastatin—Muscular weakness—Epirubicin—testicular cancer	0.000265	0.00251	CcSEcCtD
Rosuvastatin—Urticaria—Ifosfamide—testicular cancer	0.000265	0.00251	CcSEcCtD
Rosuvastatin—Abdominal pain—Ifosfamide—testicular cancer	0.000264	0.0025	CcSEcCtD
Rosuvastatin—ABCC1—seminal vesicle—testicular cancer	0.000262	0.0516	CbGeAlD
Rosuvastatin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000262	0.00249	CcSEcCtD
Rosuvastatin—Infection—Etoposide—testicular cancer	0.000262	0.00248	CcSEcCtD
Rosuvastatin—Asthenia—Dactinomycin—testicular cancer	0.000261	0.00248	CcSEcCtD
Rosuvastatin—Influenza—Epirubicin—testicular cancer	0.00026	0.00246	CcSEcCtD
Rosuvastatin—Paraesthesia—Cisplatin—testicular cancer	0.000258	0.00245	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Etoposide—testicular cancer	0.000258	0.00245	CcSEcCtD
Rosuvastatin—Pancreatitis—Epirubicin—testicular cancer	0.000255	0.00242	CcSEcCtD
Rosuvastatin—Breast disorder—Doxorubicin—testicular cancer	0.000251	0.00238	CcSEcCtD
Rosuvastatin—Bronchitis—Epirubicin—testicular cancer	0.00025	0.00237	CcSEcCtD
Rosuvastatin—Diarrhoea—Dactinomycin—testicular cancer	0.000249	0.00236	CcSEcCtD
Rosuvastatin—Depression—Methotrexate—testicular cancer	0.000247	0.00234	CcSEcCtD
Rosuvastatin—Rash—Bleomycin—testicular cancer	0.000246	0.00233	CcSEcCtD
Rosuvastatin—Pain—Cisplatin—testicular cancer	0.000246	0.00233	CcSEcCtD
Rosuvastatin—Dermatitis—Bleomycin—testicular cancer	0.000246	0.00233	CcSEcCtD
Rosuvastatin—Hypersensitivity—Ifosfamide—testicular cancer	0.000246	0.00233	CcSEcCtD
Rosuvastatin—Muscular weakness—Doxorubicin—testicular cancer	0.000245	0.00233	CcSEcCtD
Rosuvastatin—HMGCR—female gonad—testicular cancer	0.000241	0.0473	CbGeAlD
Rosuvastatin—Influenza—Doxorubicin—testicular cancer	0.00024	0.00228	CcSEcCtD
Rosuvastatin—Asthenia—Ifosfamide—testicular cancer	0.000239	0.00227	CcSEcCtD
Rosuvastatin—Feeling abnormal—Cisplatin—testicular cancer	0.000237	0.00225	CcSEcCtD
Rosuvastatin—Paraesthesia—Etoposide—testicular cancer	0.000237	0.00224	CcSEcCtD
Rosuvastatin—Pruritus—Ifosfamide—testicular cancer	0.000236	0.00224	CcSEcCtD
Rosuvastatin—Haematuria—Methotrexate—testicular cancer	0.000236	0.00224	CcSEcCtD
Rosuvastatin—Pancreatitis—Doxorubicin—testicular cancer	0.000236	0.00223	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Methotrexate—testicular cancer	0.000234	0.00222	CcSEcCtD
Rosuvastatin—Nausea—Bleomycin—testicular cancer	0.000232	0.0022	CcSEcCtD
Rosuvastatin—Bronchitis—Doxorubicin—testicular cancer	0.000231	0.00219	CcSEcCtD
Rosuvastatin—Rash—Dactinomycin—testicular cancer	0.00023	0.00218	CcSEcCtD
Rosuvastatin—Diarrhoea—Ifosfamide—testicular cancer	0.000228	0.00216	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Epirubicin—testicular cancer	0.000227	0.00215	CcSEcCtD
Rosuvastatin—Jaundice—Epirubicin—testicular cancer	0.000226	0.00214	CcSEcCtD
Rosuvastatin—Constipation—Etoposide—testicular cancer	0.000225	0.00214	CcSEcCtD
Rosuvastatin—Pain—Etoposide—testicular cancer	0.000225	0.00214	CcSEcCtD
Rosuvastatin—Urinary tract infection—Epirubicin—testicular cancer	0.000225	0.00213	CcSEcCtD
Rosuvastatin—Hepatitis—Methotrexate—testicular cancer	0.000222	0.00211	CcSEcCtD
Rosuvastatin—Haematuria—Epirubicin—testicular cancer	0.000221	0.00209	CcSEcCtD
Rosuvastatin—Dizziness—Ifosfamide—testicular cancer	0.000221	0.00209	CcSEcCtD
Rosuvastatin—Pharyngitis—Methotrexate—testicular cancer	0.000221	0.00209	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Epirubicin—testicular cancer	0.000219	0.00208	CcSEcCtD
Rosuvastatin—Sinusitis—Epirubicin—testicular cancer	0.000217	0.00206	CcSEcCtD
Rosuvastatin—Feeling abnormal—Etoposide—testicular cancer	0.000217	0.00206	CcSEcCtD
Rosuvastatin—ABCG2—seminal vesicle—testicular cancer	0.000217	0.0427	CbGeAlD
Rosuvastatin—Nausea—Dactinomycin—testicular cancer	0.000216	0.00205	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Etoposide—testicular cancer	0.000216	0.00204	CcSEcCtD
Rosuvastatin—HMGCR—testis—testicular cancer	0.000213	0.042	CbGeAlD
Rosuvastatin—Hypersensitivity—Cisplatin—testicular cancer	0.000212	0.00201	CcSEcCtD
Rosuvastatin—Rash—Ifosfamide—testicular cancer	0.00021	0.00199	CcSEcCtD
Rosuvastatin—Dermatitis—Ifosfamide—testicular cancer	0.00021	0.00199	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00021	0.00199	CcSEcCtD
Rosuvastatin—Urticaria—Etoposide—testicular cancer	0.000209	0.00199	CcSEcCtD
Rosuvastatin—Jaundice—Doxorubicin—testicular cancer	0.000209	0.00198	CcSEcCtD
Rosuvastatin—Rhinitis—Epirubicin—testicular cancer	0.000208	0.00198	CcSEcCtD
Rosuvastatin—Abdominal pain—Etoposide—testicular cancer	0.000208	0.00198	CcSEcCtD
Rosuvastatin—Urinary tract infection—Doxorubicin—testicular cancer	0.000208	0.00198	CcSEcCtD
Rosuvastatin—Hepatitis—Epirubicin—testicular cancer	0.000208	0.00197	CcSEcCtD
Rosuvastatin—Asthenia—Cisplatin—testicular cancer	0.000206	0.00196	CcSEcCtD
Rosuvastatin—Pharyngitis—Epirubicin—testicular cancer	0.000206	0.00196	CcSEcCtD
Rosuvastatin—Haematuria—Doxorubicin—testicular cancer	0.000204	0.00194	CcSEcCtD
Rosuvastatin—SLCO2B1—female gonad—testicular cancer	0.000204	0.0401	CbGeAlD
Rosuvastatin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000203	0.00192	CcSEcCtD
Rosuvastatin—Sinusitis—Doxorubicin—testicular cancer	0.000201	0.00191	CcSEcCtD
Rosuvastatin—Nausea—Ifosfamide—testicular cancer	0.000198	0.00188	CcSEcCtD
Rosuvastatin—Diarrhoea—Cisplatin—testicular cancer	0.000197	0.00187	CcSEcCtD
Rosuvastatin—Mental disorder—Methotrexate—testicular cancer	0.000195	0.00185	CcSEcCtD
Rosuvastatin—Hypersensitivity—Etoposide—testicular cancer	0.000194	0.00184	CcSEcCtD
Rosuvastatin—Rhinitis—Doxorubicin—testicular cancer	0.000193	0.00183	CcSEcCtD
Rosuvastatin—Hepatitis—Doxorubicin—testicular cancer	0.000192	0.00182	CcSEcCtD
Rosuvastatin—Pharyngitis—Doxorubicin—testicular cancer	0.000191	0.00181	CcSEcCtD
Rosuvastatin—Asthenia—Etoposide—testicular cancer	0.000189	0.00179	CcSEcCtD
Rosuvastatin—Pruritus—Etoposide—testicular cancer	0.000186	0.00177	CcSEcCtD
Rosuvastatin—Arrhythmia—Epirubicin—testicular cancer	0.000186	0.00176	CcSEcCtD
Rosuvastatin—Mental disorder—Epirubicin—testicular cancer	0.000182	0.00173	CcSEcCtD
Rosuvastatin—Rash—Cisplatin—testicular cancer	0.000181	0.00172	CcSEcCtD
Rosuvastatin—Dermatitis—Cisplatin—testicular cancer	0.000181	0.00172	CcSEcCtD
Rosuvastatin—SLCO2B1—testis—testicular cancer	0.000181	0.0356	CbGeAlD
Rosuvastatin—ABCC4—female gonad—testicular cancer	0.000181	0.0355	CbGeAlD
Rosuvastatin—Diarrhoea—Etoposide—testicular cancer	0.00018	0.00171	CcSEcCtD
Rosuvastatin—Flatulence—Epirubicin—testicular cancer	0.000178	0.00169	CcSEcCtD
Rosuvastatin—Dizziness—Etoposide—testicular cancer	0.000174	0.00165	CcSEcCtD
Rosuvastatin—Arrhythmia—Doxorubicin—testicular cancer	0.000172	0.00163	CcSEcCtD
Rosuvastatin—Nausea—Cisplatin—testicular cancer	0.000171	0.00162	CcSEcCtD
Rosuvastatin—Cough—Methotrexate—testicular cancer	0.000169	0.0016	CcSEcCtD
Rosuvastatin—Mental disorder—Doxorubicin—testicular cancer	0.000169	0.0016	CcSEcCtD
Rosuvastatin—SLCO1A2—testis—testicular cancer	0.000166	0.0327	CbGeAlD
Rosuvastatin—Rash—Etoposide—testicular cancer	0.000166	0.00158	CcSEcCtD
Rosuvastatin—Dermatitis—Etoposide—testicular cancer	0.000166	0.00157	CcSEcCtD
Rosuvastatin—ALB—testis—testicular cancer	0.000165	0.0325	CbGeAlD
Rosuvastatin—Headache—Etoposide—testicular cancer	0.000165	0.00157	CcSEcCtD
Rosuvastatin—Flatulence—Doxorubicin—testicular cancer	0.000165	0.00156	CcSEcCtD
Rosuvastatin—Myalgia—Methotrexate—testicular cancer	0.000165	0.00156	CcSEcCtD
Rosuvastatin—Arthralgia—Methotrexate—testicular cancer	0.000165	0.00156	CcSEcCtD
Rosuvastatin—ABCC4—testis—testicular cancer	0.00016	0.0315	CbGeAlD
Rosuvastatin—Confusional state—Methotrexate—testicular cancer	0.000159	0.00151	CcSEcCtD
Rosuvastatin—Cough—Epirubicin—testicular cancer	0.000158	0.0015	CcSEcCtD
Rosuvastatin—Infection—Methotrexate—testicular cancer	0.000157	0.00149	CcSEcCtD
Rosuvastatin—Nausea—Etoposide—testicular cancer	0.000157	0.00148	CcSEcCtD
Rosuvastatin—Nervous system disorder—Methotrexate—testicular cancer	0.000155	0.00147	CcSEcCtD
Rosuvastatin—HMGCR—lymph node—testicular cancer	0.000155	0.0304	CbGeAlD
Rosuvastatin—Thrombocytopenia—Methotrexate—testicular cancer	0.000155	0.00147	CcSEcCtD
Rosuvastatin—Myalgia—Epirubicin—testicular cancer	0.000154	0.00146	CcSEcCtD
Rosuvastatin—Arthralgia—Epirubicin—testicular cancer	0.000154	0.00146	CcSEcCtD
Rosuvastatin—ABCC1—female gonad—testicular cancer	0.000154	0.0303	CbGeAlD
Rosuvastatin—Confusional state—Epirubicin—testicular cancer	0.000149	0.00141	CcSEcCtD
Rosuvastatin—Infection—Epirubicin—testicular cancer	0.000147	0.00139	CcSEcCtD
Rosuvastatin—Cough—Doxorubicin—testicular cancer	0.000146	0.00139	CcSEcCtD
Rosuvastatin—Nervous system disorder—Epirubicin—testicular cancer	0.000145	0.00137	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Epirubicin—testicular cancer	0.000145	0.00137	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000144	0.00136	CcSEcCtD
Rosuvastatin—Insomnia—Methotrexate—testicular cancer	0.000143	0.00135	CcSEcCtD
Rosuvastatin—Myalgia—Doxorubicin—testicular cancer	0.000143	0.00135	CcSEcCtD
Rosuvastatin—Arthralgia—Doxorubicin—testicular cancer	0.000143	0.00135	CcSEcCtD
Rosuvastatin—Paraesthesia—Methotrexate—testicular cancer	0.000142	0.00134	CcSEcCtD
Rosuvastatin—Dyspepsia—Methotrexate—testicular cancer	0.000139	0.00132	CcSEcCtD
Rosuvastatin—Confusional state—Doxorubicin—testicular cancer	0.000138	0.00131	CcSEcCtD
Rosuvastatin—ABCC1—testis—testicular cancer	0.000137	0.0269	CbGeAlD
Rosuvastatin—Infection—Doxorubicin—testicular cancer	0.000136	0.00129	CcSEcCtD
Rosuvastatin—Pain—Methotrexate—testicular cancer	0.000135	0.00128	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000135	0.00128	CcSEcCtD
Rosuvastatin—Nervous system disorder—Doxorubicin—testicular cancer	0.000134	0.00127	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000134	0.00127	CcSEcCtD
Rosuvastatin—Insomnia—Epirubicin—testicular cancer	0.000134	0.00127	CcSEcCtD
Rosuvastatin—Paraesthesia—Epirubicin—testicular cancer	0.000133	0.00126	CcSEcCtD
Rosuvastatin—SLCO2B1—lymph node—testicular cancer	0.000131	0.0258	CbGeAlD
Rosuvastatin—Feeling abnormal—Methotrexate—testicular cancer	0.00013	0.00123	CcSEcCtD
Rosuvastatin—Dyspepsia—Epirubicin—testicular cancer	0.00013	0.00123	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000129	0.00122	CcSEcCtD
Rosuvastatin—ABCG2—female gonad—testicular cancer	0.000127	0.0251	CbGeAlD
Rosuvastatin—Pain—Epirubicin—testicular cancer	0.000126	0.0012	CcSEcCtD
Rosuvastatin—Constipation—Epirubicin—testicular cancer	0.000126	0.0012	CcSEcCtD
Rosuvastatin—Urticaria—Methotrexate—testicular cancer	0.000125	0.00119	CcSEcCtD
Rosuvastatin—Abdominal pain—Methotrexate—testicular cancer	0.000125	0.00118	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000125	0.00118	CcSEcCtD
Rosuvastatin—Insomnia—Doxorubicin—testicular cancer	0.000124	0.00117	CcSEcCtD
Rosuvastatin—Paraesthesia—Doxorubicin—testicular cancer	0.000123	0.00116	CcSEcCtD
Rosuvastatin—Feeling abnormal—Epirubicin—testicular cancer	0.000122	0.00115	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000121	0.00115	CcSEcCtD
Rosuvastatin—Dyspepsia—Doxorubicin—testicular cancer	0.00012	0.00114	CcSEcCtD
Rosuvastatin—ALB—lymph node—testicular cancer	0.00012	0.0236	CbGeAlD
Rosuvastatin—CYP3A5—female gonad—testicular cancer	0.000118	0.0233	CbGeAlD
Rosuvastatin—Urticaria—Epirubicin—testicular cancer	0.000117	0.00111	CcSEcCtD
Rosuvastatin—Constipation—Doxorubicin—testicular cancer	0.000117	0.00111	CcSEcCtD
Rosuvastatin—Pain—Doxorubicin—testicular cancer	0.000117	0.00111	CcSEcCtD
Rosuvastatin—Abdominal pain—Epirubicin—testicular cancer	0.000117	0.00111	CcSEcCtD
Rosuvastatin—Hypersensitivity—Methotrexate—testicular cancer	0.000116	0.0011	CcSEcCtD
Rosuvastatin—ABCC4—lymph node—testicular cancer	0.000116	0.0228	CbGeAlD
Rosuvastatin—Asthenia—Methotrexate—testicular cancer	0.000113	0.00107	CcSEcCtD
Rosuvastatin—ABCG2—testis—testicular cancer	0.000113	0.0222	CbGeAlD
Rosuvastatin—Feeling abnormal—Doxorubicin—testicular cancer	0.000113	0.00107	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000112	0.00106	CcSEcCtD
Rosuvastatin—Pruritus—Methotrexate—testicular cancer	0.000112	0.00106	CcSEcCtD
Rosuvastatin—Hypersensitivity—Epirubicin—testicular cancer	0.000109	0.00103	CcSEcCtD
Rosuvastatin—Urticaria—Doxorubicin—testicular cancer	0.000109	0.00103	CcSEcCtD
Rosuvastatin—Abdominal pain—Doxorubicin—testicular cancer	0.000108	0.00102	CcSEcCtD
Rosuvastatin—Diarrhoea—Methotrexate—testicular cancer	0.000108	0.00102	CcSEcCtD
Rosuvastatin—Asthenia—Epirubicin—testicular cancer	0.000106	0.00101	CcSEcCtD
Rosuvastatin—Pruritus—Epirubicin—testicular cancer	0.000105	0.000991	CcSEcCtD
Rosuvastatin—Dizziness—Methotrexate—testicular cancer	0.000104	0.00099	CcSEcCtD
Rosuvastatin—Diarrhoea—Epirubicin—testicular cancer	0.000101	0.000958	CcSEcCtD
Rosuvastatin—Hypersensitivity—Doxorubicin—testicular cancer	0.000101	0.000955	CcSEcCtD
Rosuvastatin—Rash—Methotrexate—testicular cancer	9.96e-05	0.000944	CcSEcCtD
Rosuvastatin—Dermatitis—Methotrexate—testicular cancer	9.95e-05	0.000943	CcSEcCtD
Rosuvastatin—ABCC1—lymph node—testicular cancer	9.9e-05	0.0195	CbGeAlD
Rosuvastatin—Headache—Methotrexate—testicular cancer	9.89e-05	0.000938	CcSEcCtD
Rosuvastatin—Asthenia—Doxorubicin—testicular cancer	9.81e-05	0.00093	CcSEcCtD
Rosuvastatin—Dizziness—Epirubicin—testicular cancer	9.77e-05	0.000926	CcSEcCtD
Rosuvastatin—Pruritus—Doxorubicin—testicular cancer	9.67e-05	0.000917	CcSEcCtD
Rosuvastatin—Nausea—Methotrexate—testicular cancer	9.38e-05	0.000889	CcSEcCtD
Rosuvastatin—Diarrhoea—Doxorubicin—testicular cancer	9.35e-05	0.000887	CcSEcCtD
Rosuvastatin—Rash—Epirubicin—testicular cancer	9.32e-05	0.000883	CcSEcCtD
Rosuvastatin—Dermatitis—Epirubicin—testicular cancer	9.31e-05	0.000882	CcSEcCtD
Rosuvastatin—Headache—Epirubicin—testicular cancer	9.26e-05	0.000878	CcSEcCtD
Rosuvastatin—Dizziness—Doxorubicin—testicular cancer	9.04e-05	0.000857	CcSEcCtD
Rosuvastatin—Nausea—Epirubicin—testicular cancer	8.78e-05	0.000832	CcSEcCtD
Rosuvastatin—Rash—Doxorubicin—testicular cancer	8.62e-05	0.000817	CcSEcCtD
Rosuvastatin—Dermatitis—Doxorubicin—testicular cancer	8.61e-05	0.000816	CcSEcCtD
Rosuvastatin—Headache—Doxorubicin—testicular cancer	8.56e-05	0.000812	CcSEcCtD
Rosuvastatin—ABCG2—lymph node—testicular cancer	8.19e-05	0.0161	CbGeAlD
Rosuvastatin—Nausea—Doxorubicin—testicular cancer	8.12e-05	0.00077	CcSEcCtD
